The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates

Rationale Synthetic cathinones continue to emerge in recreational drug markets worldwide. 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone) and 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone) are derivatives of the cathinone compound, 1-(1,3-benzodioxol-5-yl)-2-(methyla...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacology Vol. 236; no. 3; pp. 953 - 962
Main Authors: Saha, Kusumika, Li, Yang, Holy, Marion, Lehner, Kurt R., Bukhari, Mohammad O., Partilla, John S., Sandtner, Walter, Sitte, Harald H., Baumann, Michael H.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-03-2019
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale Synthetic cathinones continue to emerge in recreational drug markets worldwide. 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone) and 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone) are derivatives of the cathinone compound, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one (methylone), that are being detected in drug products and human casework. Objectives The purpose of the present study was to examine the neuropharmacology of butylone and pentylone using in vitro and in vivo methods. Methods In vitro uptake and release assays were carried out in rat brain synaptosomes and in cells expressing human dopamine transporters (DAT) and 5-HT transporters (SERT). In vivo microdialysis was performed in the nucleus accumbens of conscious rats to assess drug-induced changes in neurochemistry. Results Butylone and pentylone were efficacious uptake blockers at DAT and SERT, though pentylone was more DAT-selective. Both drugs acted as transporter substrates that evoked release of [ 3 H]5-HT at SERT, while neither evoked release at DAT. Consistent with the release data, butylone and pentylone induced substrate-associated inward currents at SERT but not DAT. Administration of butylone or pentylone to rats (1 and 3 mg/kg, i.v.) increased extracellular monoamines and motor activity, but pentylone had weaker effects on 5-HT and stronger effects on motor stimulation. Conclusions Our data demonstrate that increasing the α-carbon chain length of methylone creates “hybrid” transporter compounds which act as DAT blockers but SERT substrates. Nevertheless, butylone and pentylone elevate extracellular dopamine and stimulate motor activity, suggesting both drugs possess significant risk for abuse.
Bibliography:AUTHORSHIP CONTRIBUTIONS
MHB designed and oversaw in vitro and in vivo experiments in animals. JSP carried out uptake inhibition and release assays in synaptosomes, whereas KRL and MOB carried out microdialysis experiments in rats. HHS designed and oversaw experiments in HEK-293 cells transfected with human DAT and SERT. KS, YL, MH and WS carried out experiments in transfected cells. MHB and HHS analyzed data. KS and MHB wrote the first draft of the paper, and all other authors contributed significantly to the writing of the final manuscript.
ISSN:0033-3158
1432-2072
DOI:10.1007/s00213-018-5075-5